After AI express, investors ask questions on the investor interaction platform: Hello, the company announced that covid-19 kit was approved by the EU two years ago. At present, it has not formed a sales form? If not, how does the company deal with the of relevant responsible persons?
Beijing Bohui Innovation Biotechnology Group Co.Ltd(300318) (300318. SZ) said on the investor interaction platform on February 25 that the company will comprehensively consider the competition in relevant markets and the company’s channel ability and formulate corresponding market development strategies. At present, it is further applying for access in some countries and regions in South America and Southeast Asia. However, due to the need to invest a lot of time and resources in overseas market development, So far, no sales have been formed.
